Advisory Services Network, LLC Vir Biotechnology, Inc. Transaction History

Advisory Services Network, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$7.76 - $10.29 $776 - $1,029	100 New	100 $1,000
Q1 2023 May 17, 2023	BUY	$22.26 - $30.85 $1,113 - $1,542	50 New	50 $1,000
Q4 2020 Feb 09, 2021	SELL	$25.51 - $43.38 $8,749 - $14,879	-343 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$28.28 - $53.6 $9,700 - $18,384	343 New	343 $12,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.